Brief: Finch Therapeutics Group Inc - As A Result Of Restructuring Estimates That It Will Incur Approximately $4.1 Million In Costs
24/01/2023 13:10
Jan 24 (Reuters) - Finch Therapeutics Group Inc
FNCH.O :
* FINCH THERAPEUTICS GROUP INC - AS A RESULT OF
RESTRUCTURING
ESTIMATES THAT IT WILL INCUR APPROXIMATELY $4.1 MILLION IN COSTS
* FINCH THERAPEUTICS GROUP INC - EXPECTS TO RECORD A
SIGNIFICANT
PORTION OF RESTRUCTURING CHARGES IN FIRST HALF OF 2023
* FINCH THERAPEUTICS GROUP INC - RESTRUCTURING EXPECTED TO
BE
SUBSTANTIALLY COMPLETE BY END OF Q2 OF 2023
* FINCH THERAPEUTICS GROUP INC - ON JANUARY 23, 2023 BOARD
APPROVED REDUCTION OF COMPANY'S WORKFORCE BY 77 FULL-TIME
EMPLOYEES
Further company coverage: FNCH.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Finch Therapeutics
See all newsFinch wins US jury trial against Ferring over fecal-transplant patents
Brief: Finch Therapeutics Group Received A Notice From Nasdaq Acknowledging Fact That Co Does Not Meet Requirements Of Rules On April 2
Brief: Finch Therapeutics Got Letter From Nasdaq That Co Has Regained Compliance With Nasdaq’s Listing Rule 5450(A)(1)
U.S. STOCKS ON THE MOVE-Gold miners, ImmunoGen, Oracle
U.S. STOCKS ON THE MOVE-Teekay, gold miners, Oil-Dri Corp